Kremoint Pharma Private Limited · 66-41 · INDIA
For Kremoint Pharma Private Limited, import alert is 66-41; country is INDIA; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; product is White Express Creme Action Rapide Formule Avancee | Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline) | Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline) | Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline) | Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline) | White Express Creme Action Rapide Formule Avancee | Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline); product code is 53 L - - 06 Moisturizing (Skin Care Preparations) | 56 D - - 20 Gentamicin (Aminoglycosides) | 61 A - - 11 Iodochlorhydroxyquin (Anti-Amebic) | 61 W - - 31 Tolnaftate (Anti-Fungal) (Not Antibiotic) | 64 L - - 06 Betamethasone Dipropionate (Glucocorticoid) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 05/03/2018; address is B-8, Additional Ambernath M.I.D.C. , Ambernath (E), Thane District , Mumbai, Maharashtra INDIA, verified against its source on 2026-10-01.
- Firm
- Kremoint Pharma Private Limited verified
- Import alert
- 66-41
- Import alert name
- Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- Country
- INDIA verified
- Address
- B-8, Additional Ambernath M.I.D.C. , Ambernath (E), Thane District , Mumbai, Maharashtra INDIA verified
- Date published
- 05/03/2018 verified
- Product code
- 53 L - - 06 Moisturizing (Skin Care Preparations) | 56 D - - 20 Gentamicin (Aminoglycosides) | 61 A - - 11 Iodochlorhydroxyquin (Anti-Amebic) | 61 W - - 31 Tolnaftate (Anti-Fungal) (Not Antibiotic) | 64 L - - 06 Betamethasone Dipropionate (Glucocorticoid) | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
- Product
- White Express Creme Action Rapide Formule Avancee | Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline) | Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline) | Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline) | Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline) | White Express Creme Action Rapide Formule Avancee | Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline) each item verified
- FDA notes
- A labeling statement documenting the intended use of the product include, but may not be limited to the following: “Anti-Fungal”, “Anti-Bacterial” and “Anti-Inflammatory”. | A labeling statement documenting the intended use of the product include, but may not be limited to the following: “Anti-Fungal”, “Anti-Bacterial” and “Anti-Inflammatory”. | A labeling statement documenting the intended use of the product include, but may not be limited to the following: “Anti-Fungal”, “Anti-Bacterial” and “Anti-Inflammatory”. | A labeling statement documenting the intended use of the product include, but may not be limited to the following: “Anti-Fungal”, “Anti-Bacterial” and “Anti-Inflammatory”. | A labeling statement documenting the intended use of the product include, but may not be limited to the following: “Anti-Fungal”, “Anti-Bacterial” and “Anti-Inflammatory”. each item verified
What the source says
Kremoint Pharma Private Limited Date Published : 05/03/2018 B-8, Additional Ambernath M.I.D.C. , Ambernath (E), Thane District , Mumbai, Maharashtra INDIA
— accessdata.fda.gov, retrieved 2026-09-24
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Product code, Product and FDA notes
53 L - - 06 Moisturizing (Skin Care Preparations) Date Published: 05/03/2018 Desc: White Express Creme Action Rapide Formule Avancee 56 D - - 20 Gentamicin (Aminoglycosides) Date Published: 10/01/2021 Desc: Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline) Notes: A labeling statement documenting the intended use of the product include, but may not be limited to the following: “Anti-Fungal”, “Anti-Bacterial” and “Anti-Inflammatory”. 61 A - - 11 Iodochlorhydroxyquin (Anti-Amebic) Date Published: 10/01/2021 Desc: Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline) Notes: A labeling statement documenting the intended use of the product include, but may not be limited to the following: “Anti-Fungal”, “Anti-Bacterial” and “Anti-Inflammatory”. 61 W - - 31 Tolnaftate (Anti-Fungal) (Not Antibiotic) Date Published: 10/01/2021 Desc: Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline) Notes: A labeling statement documenting the intended use of the product include, but may not be limited to the following: “Anti-Fungal”, “Anti-Bacterial” and “Anti-Inflammatory”. 64 L - - 06 Betamethasone Dipropionate (Glucocorticoid) Date Published: 10/01/2021 Desc: Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline) Notes: A labeling statement documenting the intended use of the product include, but may not be limited to the following: “Anti-Fungal”, “Anti-Bacterial” and “Anti-Inflammatory”. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 05/03/2018 Desc: White Express Creme Action Rapide Formule Avancee 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 10/01/2021 Desc: Neutroderm Cream (Betamethasone Dipropionate/Gentamicin/Tolnaftate/Iodochlorhydroxyquinoline) Notes: A labeling statement documenting the intended use of the product include, but may not be limited to the following: “Anti-Fungal”, “Anti-Bacterial” and “Anti-Inflammatory”.
— all from accessdata.fda.gov, retrieved 2026-09-24
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_190.html